Clinical Studies
Evidence for Cannabis‑Based Therapies
Avextra invests intentionally in clinical research to demonstrate the efficacy, safety, and clinical relevance of cannabis‑based prescription medicines – from controlled trials to real‑world data.
Research Strategy:
Focus on randomized, controlled Phase II studies in selected indications.
Clinical Study Programs
Multicenter, interventional Phase II study in supportive care for oncology patients, addressing high unmet medical needs.
TYP
Phase II · Interventional
STATUS
Ongoing
Interventional Phase II clinical trial in Italy investigating cannabis-based medicines in neurodegenerative diseases such as ALS, Parkinson’s, and Alzheimer’s disease.
TYP
Phase II · Interventional
STATUS
Ongoing
Non-interventional real-world study evaluating cannabis-based medicines in chemotherapy-induced neuropathic pain.
TYP
Real-World Evidence
STATUS
Completed
Multicenter real-world observational study assessing patient experience, treatment satisfaction, and quality of life with oral cannabis formulations.
TYP
Real-World Evidence
STATUS
Completed
Prospective observational study evaluating sleep quality and quality of life in patients with chronic pain.
TYP
Observational Study
STATUS
Completed
Observational real-world study assessing the use of cannabis-based prescription medicines in palliative care settings.
TYP
Real-World Evidence
STATUS
Completed
Prospective observational study investigating cannabis-based prescription medicines for psychological symptoms in palliative care.
TYP
Interventional Study
STATUS
Ongoing
Healthcare professionals can access further information about the studies in our DocCheck section. Please confirm your professional status by logging in with your DocCheck account.
Please note that these information are only available in German.
If you have any questions, please contact our Clinical Operations team
(Monday to Friday from 8:00 a.m.—4:00 p.m.)
